ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,630Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 1692

$1.08M Total Retail Price of All Prescriptions

Rank: 32 out of 1692

757 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 757 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 757 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 15,178 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 1,221 672 S3 1 6
OMEPRAZOLE 938 527 2 5
SIMVASTATIN 605 409 3 1
LISINOPRIL 600 348 4 2
FUROSEMIDE 590 480 5 7
LEVOTHYROXINE SODIUM 492 341 6 4
METFORMIN HCL 481 249 7 8
AMLODIPINE BESYLATE 454 342 8 3
METOPROLOL TARTRATE 453 365 9 10
ATENOLOL 449 328 10 15
PRAVASTATIN SODIUM 421 279 11 12
POTASSIUM CHLORIDE 408 333 12 20
GABAPENTIN 335 188 13 13
RANITIDINE HCL 332 180 14 28
HYDROCHLOROTHIAZIDE 307 242 15 9
TRAMADOL HCL 270 160 16 16
TRAZODONE HCL 263 157 17 33
ENDOCET 262 86 S2 18 132
PROAIR HFA 260 147 19 40
METOPROLOL SUCCINATE 245 168 20 18
WARFARIN SODIUM 236 205 21 14
OXYCODONE HCL-ACETAMINOPHEN 229 65 S2 22 94
PROMETHAZINE HCL 222 81 R 23 81
LOSARTAN POTASSIUM 214 193 24 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 213 149 25 19
PANTOPRAZOLE SODIUM 210 146 26 39
OXYCODONE HCL 191 28 S2 27 56
GEMFIBROZIL 174 73 28 98
LOSARTAN-HYDROCHLOROTHIAZIDE 174 105 28 38
CITALOPRAM HBR 174 82 28 21
NEXIUM 170 114 31 25
ATORVASTATIN CALCIUM 166 74 32 11
SPIRIVA 161 116 33 44
MELOXICAM 153 75 34 41
PREDNISONE 151 136 35 35
ALLOPURINOL 151 120 35 30
TIZANIDINE HCL 147 36 37 127
DILTIAZEM 24HR CD 143 135 38 96
TAMSULOSIN HCL 141 122 39 31
ZOLPIDEM TARTRATE 141 66 39 23
METFORMIN HCL ER 140 114 41 49
CLONIDINE HCL 137 93 42 46
POLYETHYLENE GLYCOL 3350 134 96 43 64
CLOPIDOGREL 133 105 44 43
ISOSORBIDE MONONITRATE ER 130 130 45 55
CYCLOBENZAPRINE HCL 129 62 R 46 54
VENTOLIN HFA 125 89 47 151
SYMBICORT 124 90 48 166
FLUTICASONE PROPIONATE 121 66 49 27
TERAZOSIN HCL 117 77 50 128
SERTRALINE HCL 115 41 51 22
PLAVIX 114 95 52 66
FENTANYL 113 84 S2 53 88
DONEPEZIL HCL 112 101 54 29
CARVEDILOL 110 103 55 24
ROPINIROLE HCL 109 32 56 101
SINGULAIR 108 91 57 79
LOVASTATIN 107 76 58 37
DIGOXIN 106 105 59 85
NAPROXEN 95 40 60 91
ALENDRONATE SODIUM 94 68 61 36
GLIMEPIRIDE 93 72 62 32
VENLAFAXINE HCL ER 92 35 63 84
WELCHOL 88 50 64 217
FINASTERIDE 87 71 65 99
CARISOPRODOL 87 32 R 65 137
METOCLOPRAMIDE HCL 86 65 67 146
MECLIZINE HCL 85 65 68 124
THEOPHYLLINE ANHYDROUS 85 83 68 210
ENALAPRIL MALEATE 84 73 70 71
HYDROXYZINE HCL 82 49 R 71 182
CIPROFLOXACIN HCL 82 65 71 65
AZITHROMYCIN 81 47 73 34
LANTUS 80 34 74 57
COMBIVENT 79 52 75 141
CHLORTHALIDONE 76 46 76 143
AMLODIPINE BESYLATE-BENAZEPRIL 75 66 77 67
LANSOPRAZOLE 74 40 78 133
QUETIAPINE FUMARATE 73 48 79 62
IBUPROFEN 73 22 79 78
AMOXICILLIN 72 46 81 95
ADVAIR DISKUS 71 54 82 45
CYMBALTA 70 13 83 51
NAMENDA 70 59 83 50
GLIPIZIDE 69 57 85 47
DOXEPIN HCL 69 58 85 204
SYNTHROID 68 61 87 59
DILTIAZEM 24HR ER 64 42 88 134
SULFAMETHOXAZOLE-TRIMETHOPRIM 64 48 88 100
JANUVIA 64 33 88 72
CARBAMAZEPINE 63 23 91 207
DOXAZOSIN MESYLATE 63 51 91 83
CEFUROXIME 63 44 91 153
ZETIA 63 50 91 68
BUSPIRONE HCL 62 42 95 122
MORPHINE SULFATE ER 62 19 S2 95 121
FAMOTIDINE 61 45 97 86
NABUMETONE 61 36 97 158
ULORIC 60 48 99 427
CEPHALEXIN 59 35 100 89
LACTULOSE 59 50 100 104
METHOCARBAMOL 59 22 R 100 179
PAROXETINE HCL 58 39 103 60
BACLOFEN 57 26 104 115
SPIRONOLACTONE 56 43 105 74
LABETALOL HCL 56 34 105 207
CELEBREX 55 47 107 103
DILTIAZEM ER 54 42 108 174
NORTRIPTYLINE HCL 54 24 108 202
MIRTAZAPINE 54 43 108 53
MONTELUKAST SODIUM 53 39 111 144
DOXYCYCLINE HYCLATE 53 20 111 126
AVODART 52 52 113 173
AGGRENOX 52 52 113 193
BYSTOLIC 52 41 113 129
ACTOS 52 50 113 117
NITROGLYCERIN PATCH 51 38 117 269
SUCRALFATE 51 38 117 172
CRESTOR 51 33 117 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.